[Effects of rhodiola rosea on oxidative stress and negative emotional states in patients with obstructive sleep apnea]

Yu et al., 2019 | Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi | Rct

Citation

Yu H L, Zhang P P, ... Fu A S. [Effects of rhodiola rosea on oxidative stress and negative emotional states in patients with obstructive sleep apnea]. Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2019-Oct;33(10):954-957. doi:10.13201/j.issn.1001-1781.2019.10.013

Abstract

Objective:The aim of this study is to investigate the effects of rhodiola rosea on oxidative stress, anxiety and depression in patients with OSA. Method:Ninety patients with moderate and severe OSA patients with negative emotions diagnosed by PSG, self-rating depression scale （SDS） and self-rating anxiety scale （SAS） were selected from the respiratory department of our hospital from February 2015 to February 2018. According to the random number table method, the patients were randomly divided into non-invasive ventilator group, rhodiola rosea+non-invasive ventilator group and rhodiola rosea group, with 30 cases in each group. Patients in the non-invasive ventilator group were treated with continuous positive airway pressure （CPAP） for 3 months, and those in the rhodiola rosea+non-invasive ventilator group were treated with oral rhodiola capsules for 3 months on the basis of CPAP, and those in the rhodiola rosea treatment group were treated with pure oral rhodiola capsules for 3 months. The changes of SDS and SAS before and after the three groups were compared, and the changes of serum SOD and MDA were detected by immunoenzyme-linked adsorption for comparative analysis. Result:There were no significant differences in SDS and SAS scores between the three groups （P>0.05）. SDS and SAS scores of patients in the rhodiola rosea+non-invasive ventilator group decreased after treatment （P<0.05） compared with those in the non-invasive ventilator group. SDS and SAS scores of patients in the rhodiola treatment group increased after treatment （P<0.05）. Compared with those in the rhodiola treatment group, SDS and SAS scores of patients in the rhodiola+non-invasive breathing group decreased after treatment （P<0.05）. Three group patients were no significant difference in serum SOD and malondialdehyde （MDA） before treatment （P>0.05）. Compared with before treatment, serum SOD level were all increased and MDA level were all decreased in the three groups after treatment （P<0.05）. Compared with noninvasive breathing unit after treatment, rhodiola+noninvasive breathing unit after treatment in patients with elevated levels of serum SOD, MDA level decreased （P<0.05）, and for the treatment group after treatment in patients with serum SOD levels drop, the MDA levels （P<0.05）, and the after rhodiola rosea treatment group compared, rhodiola+noninvasive breathing unit after treatment in patients with elevated levels of serum SOD, MDA level decreased （P<0.05）. Conclusion:Rhodiola may improve the negative emotions such as anxiety and depression by inhibiting oxygen free radicals and lipid peroxidation in patients with OSA.

Key Findings

Rhodiola may improve the negative emotions such as anxiety and depression by inhibiting oxygen free radicals and lipid peroxidation in patients with OSA.

Outcomes Measured

• anxiety
• depression

Population

MeSH Terms

• Continuous Positive Airway Pressure
• Humans
• Malondialdehyde
• Oxidative Stress
• Plant Extracts
• Rhodiola
• Sleep Apnea, Obstructive
• Stress, Psychological

Evidence Classification

• Level: Rct
• Publication Types: Journal Article, Randomized Controlled Trial
• Vertical: rhodiola-fatigue

Provenance

• PMID: 31623042
• DOI: 10.13201/j.issn.1001-1781.2019.10.013
• PMCID: Not in PMC
• Verified: 2026-04-09 via PubMed E-utilities API

Source extracted via PubMed E-utilities API on 2026-04-09